Skip to content

Course date

Training Course: Pharmaceutical Business Development – Los Angeles (USA), 23–27 Nov 2026

Driving growth and strategic opportunities in pharmaceuticals

Dates
City
Los Angeles (USA)
Fee
£5,900
Course code
LM3255382

This session: 23 - 27 Nov 2026

This Pharmaceutical Business Development session in Los Angeles (USA) runs from Monday 23 November to Friday 27 November 2026 (week 48, Q4 2026). It is the only date in Los Angeles (USA) in 2026, at a fee of ⁦£5,900⁩, the same for each of them. Registration is open for this date. It is held in person.

DatesMonday 23 Nov – Friday 27 Nov 2026
Week48 of 2026
DurationOne week
Fee£5,900
StatusOpen for registration
FormatIn person

Other dates for this course

Introduction

Pharmaceutical business development plays a crucial role in driving organizational growth and innovation within the life sciences sector. Among its core strategies, in-licensing stands out as a key mechanism that enables companies to expand their product portfolios, access cutting-edge technologies, and strengthen competitive advantage in a highly regulated and dynamic marketplace.

This advanced training program provides participants with an in-depth understanding of in-licensing frameworks, including how to evaluate business opportunities, negotiate effectively with potential partners, and manage legal and regulatory obligations associated with licensing agreements.

The course is designed for senior and mid-level executives, business development managers, regulatory affairs professionals, and legal teams seeking to enhance their strategic capabilities in pharmaceutical deal-making. By the end of the program, participants will acquire practical insights and analytical tools to make informed licensing decisions that align with their organization’s long-term objectives.

Course Objectives

  • Understand the strategic foundations of pharmaceutical business development.
  • Analyze product life cycles and identify stages for in-licensed product integration.
  • Evaluate commercial and technical opportunities for in-licensing partnerships.
  • Apply valuation and due diligence methodologies for assessing potential deals.
  • Strengthen negotiation and contract management capabilities.
  • Master the legal and regulatory considerations governing licensing activities.
  • Build and manage sustainable external partnerships.
  • Integrate in-licensed assets into broader corporate and product strategies.

Course Outlines

Day 1: Strategic Foundations of Pharmaceutical Business Development

  • Overview of business development functions in the pharmaceutical industry.
  • Defining growth objectives through in-licensing strategies.
  • Distinguishing between in-licensing and out-licensing models.
  • Global trends shaping licensing and alliance management.
  • Identifying and screening potential partners.
  • Case studies of successful in-licensing models.

Day 2: Opportunity Assessment and Commercial Feasibility

  • Key steps in identifying in-licensing opportunities.
  • Market and technical valuation approaches.
  • Financial modeling and forecasting expected returns.
  • Risk assessment and return-on-investment analysis.
  • Preparing business case presentations for executive decision-making.
  • Practical workshop on evaluating a real licensing case.

Day 3: Legal and Regulatory Frameworks

  • Overview of legal structures in pharmaceutical licensing.
  • Essential components of licensing and technology transfer agreements.
  • Intellectual property and patent protection management.
  • Compliance requirements and regulatory due diligence.
  • Managing confidentiality, liability, and exclusivity clauses.
  • Hands-on session analyzing sample licensing agreements.

Day 4: Negotiation Strategies and Partnership Management

  • Core principles of strategic negotiation in licensing.
  • Identifying stakeholder priorities and aligning mutual interests.
  • Building trust and long-term collaboration frameworks.
  • Structuring win-win negotiation scenarios.
  • Managing disputes and post-deal communication.
  • Simulation exercise: live negotiation between two pharmaceutical partners.

Day 5: Integration and Strategic Implementation

  • Aligning in-licensing with corporate strategy and R&D goals.
  • Integrating in-licensed products into the company’s portfolio.
  • Developing monitoring and performance-tracking systems.
  • Setting key performance indicators for partnership success.
  • Reporting licensing outcomes to executive leadership.
  • Final workshop and participant project presentations.

Why Attend This Course: Wins & Losses!

  • Gain an expert understanding of in-licensing processes in the pharmaceutical sector.
  • Enhance analytical and decision-making skills in evaluating partnership opportunities.
  • Improve negotiation effectiveness and deal-structuring competence.
  • Acquire practical knowledge of legal and regulatory compliance in licensing.
  • Strengthen organizational capacity for sustainable business growth.
  • Learn from real-world examples and industry best practices.
  • Build valuable professional connections across the life sciences sector.
  • Prepare for advanced leadership roles in business development and licensing.

Conclusion

This intensive training course provides an advanced framework for mastering the strategic, legal, and operational dimensions of pharmaceutical in-licensing. Through a blend of theory, case analysis, and applied exercises, participants will gain the practical skills necessary to identify valuable assets, structure effective partnerships, and drive organizational growth through well-executed licensing strategies.

By completing this program, professionals will be better equipped to lead business development initiatives that foster innovation, optimize resource utilization, and create long-term value in the ever-evolving pharmaceutical landscape.

Other dates for this course

  1. Fee £5,200

    Apply now Enquire PDF
  2. Fee £5,200

    Apply now Enquire PDF
  3. Fee £5,200

    Apply now Enquire PDF
  4. Fee £5,200

    Apply now Enquire PDF
  5. Fee £2,200

    Apply now Enquire PDF
  6. Fee £5,900

    Apply now Enquire PDF

All dates and locations

Good to know

How long is the course, and what are the daily hours?

This date lasts one week: 23 - 27 Nov 2026. A one-week course is 20 hours over 5 days: 4 hours each training day (9am – 1pm). Timing and duration can be customised to your needs.

From the FAQ: What is my daily training agenda?

Which language is the course taught in?

Courses are offered in English and Arabic. The course language is officially English; on request, it can be delivered in Arabic while keeping the English terms.

From the FAQ: In which language do you offer your training courses?

Will I receive a certificate?

Yes. At the end of the course you receive the course certificate issued by BlackBird Training, with an online QR code to verify it.

From the FAQ: Do I receive the certificate at the end of the course?

How do I book, and when do I pay?

Choose Apply now and fill in the form; we guide you through the rest. The acceptance letter is sent within 24 hours of your registration. Payment is due at least 10 days before the course starts, online by credit card or by bank transfer.

From the FAQ: How can I register for a training course in BlackBird?, When do I get my Acceptance Letter?, When do I need to pay?, How can I pay for the course?

Can I cancel or send a colleague instead?

You can send a replacement delegate if you tell us one week before the course starts. Cancellation and refund terms are set out in the cancellation policy.

From the FAQ: Can I send a replacement delegate?

All frequently asked questions Contact us

Enquire about this date

Pharmaceutical Business Development, Los Angeles (USA), 23 - 27 Nov 2026

Required